Vaccines List

NanoFlu Influenza Vaccine

NanoFlu is an influenza vaccine candidate which is a recombinant hemagglutinin (HA) protein nanoparticle influenza vaccine produced in an Sf9 insect cell-baculovirus system.Read more...

NanoVax Herpes Simplex Virus Vaccine

NanoVax is an adjuvant platform used in the development of a vaccine candidate that will provide protection against the two viruses that can cause genital herpes. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.Read more...

NasoVAX Influenza Vaccine

NasoVAX is a recombinant intranasal vaccine that is being developed for both seasonal and pandemic use. Read more...

NEO-PV-01 Cancer Vaccine

NEO-PV-01  Cancer vaccine candidate is a personal neoantigen vaccine which is custom designed and manufactured for each individual patient.Read more...

NeoVax Cancer Vaccine

NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.Read more...

New Crown COVID-19 Vaccine

New Crown COVID-19 is an inactivated vaccine that is made of virus particles that are grown in culture and lack disease-producing capability.Read more...

Nexvax2 - Celiac Disease Vaccine

Nexvax2 is a combination of three proprietary peptides that elicit an immune response in patients with celiac disease (CeD) who carry the immune recognition gene, HLA-DQ2.5, which accounts for the condition in 80% to 90% of patients.Read more...

Niprab Nipah Virus Vaccine

Niprab, a pre-clinical vaccine candidate, is a novel recombinant vaccine that uses a modified rabies virus vector and incorporates a gene from Nipah virus Read more...

NOUS-209 Cancer Vaccine

NOUS-209 is an off-the-shelf therapeutic vaccine based on shared tumor neoantigens.Read more...

NVX-CoV2373 SARS-CoV-2 Vaccine

NVX-CoV2372 is a stable, prefusion protein SARS-CoV-2 coronavirus vaccine candidate made using Novavax’ proprietary nanoparticle technology.Read more...